Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • The impact of COVID-19 on pati...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
The impact of COVID-19 on patients with preexisting interstitial lung disease: High mortality in these high-risk patients

The impact of COVID-19 on patients with preexisting interstitial lung disease: High mortality in these high-risk patients

Bibliographic Details
Main Authors: Zarir Farokh Udwadia, Parvaiz A Koul, Sahajal Dhooria
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Lung India
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2021;volume=38;issue=7;spage=1;epage=3;aulast=Udwadia
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.lungindia.com/article.asp?issn=0970-2113;year=2021;volume=38;issue=7;spage=1;epage=3;aulast=Udwadia

Similar Items

  • Post-COVID lung fibrosis: The tsunami that will follow the earthquake
    by: Zarir F Udwadia, et al.
    Published: (2021-01-01)
  • Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids
    by: Zarir Farokh Udwadia, et al.
    Published: (2021-01-01)
  • Idiopathic nonspecific interstitial pneumonia: Waters remain murky…remember ABCDEFGHI
    by: Sahajal Dhooria
    Published: (2024-04-01)
  • Severe interstitial lung disease persisting 2 years post-COVID-19 despite anti-fibrotic therapy
    by: Zarir F Udwadia, et al.
    Published: (2022-01-01)
  • Is pirfenidone ready for use in non-idiopathic pulmonary fibrosis interstitial lung diseases?
    by: Sahajal Dhooria, et al.
    Published: (2015-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs